BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2669592)

  • 1. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course.
    Clark JG; Crawford SW; Madtes DK; Sullivan KM
    Ann Intern Med; 1989 Sep; 111(5):368-76. PubMed ID: 2669592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airways obstruction associated with graft versus host disease after bone marrow transplantation.
    Wyatt SE; Nunn P; Hows JM; Yin J; Hayes MC; Catovsky D; Gordon-Smith EC; Hughes JM; Goldman JM; Galton D
    Thorax; 1984 Dec; 39(12):887-94. PubMed ID: 6393415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for airflow obstruction in recipients of bone marrow transplants.
    Clark JG; Schwartz DA; Flournoy N; Sullivan KM; Crawford SW; Thomas ED
    Ann Intern Med; 1987 Nov; 107(5):648-56. PubMed ID: 3310793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant obstructive lung disease ("bronchiolitis obliterans"): a clinical comparative study of bone marrow and lung transplant patients.
    Philit F; Wiesendanger T; Archimbaud E; Mornex JF; Brune J; Cordier JF
    Eur Respir J; 1995 Apr; 8(4):551-8. PubMed ID: 7664853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Obstructive lung disease after allogenic stem cell transplantation in children].
    Alonso Riofrío R; Villa Asensi JR; Sequeiros González A; Díaz Pérez MA; González Vicent M; Madero López L
    An Pediatr (Barc); 2004 Aug; 61(2):124-30. PubMed ID: 15274876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation.
    Schwarer AP; Hughes JM; Trotman-Dickenson B; Krausz T; Goldman JM
    Transplantation; 1992 Dec; 54(6):1002-8. PubMed ID: 1465767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstructive lung disease in children after allogeneic bone marrow transplantation: evaluation with high-resolution CT.
    Sargent MA; Cairns RA; Murdoch MJ; Nadel HR; Wensley D; Schultz KR
    AJR Am J Roentgenol; 1995 Mar; 164(3):693-6. PubMed ID: 7863896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic graft-versus-host disease and pulmonary function.
    Kaplan EB; Wodell RA; Wilmott RW; Leifer B; Lesser ML; August CS
    Pediatr Pulmonol; 1992 Nov; 14(3):141-8. PubMed ID: 1480439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation.
    Curtis DJ; Smale A; Thien F; Schwarer AP; Szer J
    Bone Marrow Transplant; 1995 Jul; 16(1):169-73. PubMed ID: 7581118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive airways disease after bone marrow transplantation.
    Johnson FL; Stokes DC; Ruggiero M; Dalla-Pozza L; Callihan TR
    J Pediatr; 1984 Sep; 105(3):370-6. PubMed ID: 6381680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary function after bone marrow transplantation for chronic myeloid leukaemia.
    Sutedja TG; Apperley JF; Hughes JM; Aber VR; Kennedy HG; Nunn P; Jones L; Hopper L; Goldman JM
    Thorax; 1988 Mar; 43(3):163-9. PubMed ID: 3043753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstructive lung disease after allogeneic bone marrow transplantation.
    Kurzrock R; Zander A; Kanojia M; Vellekoop L; Spitzer G; Jagannath S; Schell S; Peters L; Dicke K
    Transplantation; 1984 Feb; 37(2):156-60. PubMed ID: 6364498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of pulmonary function tests after marrow transplantation predict nonrelapse mortality.
    Crawford SW; Pepe M; Lin D; Benedetti F; Deeg HJ
    Am J Respir Crit Care Med; 1995 Aug; 152(2):690-5. PubMed ID: 7633727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung function changes after allogenic bone marrow transplantation.
    Link H; Reinhard U; Blaurock M; Ostendorf P
    Thorax; 1986 Jul; 41(7):508-12. PubMed ID: 3538484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation.
    Sánchez J; Torres A; Serrano J; Román J; Martín C; Pérula L; Martínez F; Gómez P
    Bone Marrow Transplant; 1997 Sep; 20(5):403-8. PubMed ID: 9339757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation.
    Payne L; Chan CK; Fyles G; Hyland RH; Bafundi P; Yeung M; Messner H
    Chest; 1993 Jul; 104(1):114-8. PubMed ID: 8325051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation.
    Marras TK; Chan CK; Lipton JH; Messner HA; Szalai JP; Laupacis A
    Bone Marrow Transplant; 2004 Mar; 33(5):509-17. PubMed ID: 14716347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre.
    Bruno B; Souillet G; Bertrand Y; Werck-Gallois MC; So Satta A; Bellon G
    Bone Marrow Transplant; 2004 Jul; 34(2):143-7. PubMed ID: 15170172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late pulmonary impairment following allogeneic bone marrow transplantation.
    Beinert T; Düll T; Wolf K; Holler E; Vogelmeier C; Behr J; Kolb H
    Eur J Med Res; 1996 Apr; 1(7):343-8. PubMed ID: 9364037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.